Bronchitis
📧 Sign up to get email alerts when something new happens for Bronchitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 study completed evaluating the safety and tolerability of AZD5069 in patients with moderate-to-severe chronic obstructive pulmonary …
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease [NA]
This completed clinical trial evaluated whether adding pedometer-based activity augmentation to pulmonary rehabilitation improves physical a…
-
FDA approval · 2014-12-21FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for sulfamethoxazole and trimethoprim from Amneal Pharmaceuticals of New York LLC. The approval cove…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Efficacy of Vakum Technology in Patients With Chronic Hypersecretion [NA]
Clinical trial update assessing the efficacy of Vakum Technology in patients with chronic hypersecretion related to chronic bronchitis, bron…
-
CLINICAL_TRIALS trial_result · 2014-12-01Clinical Trial Update: Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis [Phase 4]
Phase 4 trial comparing moxifloxacin to amoxicillin-clavulanic acid for acute exacerbations of chronic bronchitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Improving the Quality of End-of-Life Communication for Patients With Chronic Obstructive Pulmonary Disease (COPD) [NA]
A completed clinical trial focused on improving end-of-life communication for patients with COPD, with results posted in 2014.
-
FDA approval · 2014-11-08FDA Approved: LEVOFLOXACIN — Supplemental Application (Sagent Pharmaceuticals)
The FDA approved a supplemental application for Levofloxacin submitted by Sagent Pharmaceuticals, approving changes to the generic labeling …
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis [Phase 3]
Phase 3 trial evaluating intermittent moxifloxacin therapy to prevent acute exacerbations in chronic bronchitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Functional Implications of TNF
This update reports on a completed NIEHS-sponsored trial examining the functional implications of tumor necrosis factor (TNF) in bronchitis.
-
CLINICAL_TRIALS trial_result · 2014-09-26Clinical Trial Update: A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on) [Phase 2]
A Phase 2 multicenter, randomized, double-blind trial evaluated the dose optimization of HL301 (mixed extract of Rehmannia glutinosa, Schisa…
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: The Effects of Tiotropium on the Cough Reflex in Patients With Chronic Obstructive Pulmonary Disease (COPD) [EARLY_Phase 1]
An early-phase 1 trial evaluated the effects of tiotropium on the cough reflex in people with chronic obstructive pulmonary disease and chro…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD) [Phase 3]
This Phase 3 trial update reports on the efficacy and safety of tiotropium compared with salmeterol and placebo in patients with chronic obs…
-
CLINICAL_TRIALS trial_result · 2014-06-23Clinical Trial Update: SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe Acute Exacerbations of Chronic Bronchitis (AECB)
SYMPROVE III is a health services research trial sponsored by Bayer evaluating treatment during moderate to severe acute exacerbations of ch…
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Safety and Efficacy of KALOMIN™ Tab. in Patients With Acute Bronchitis [Phase 3]
Phase 3 trial evaluating safety and efficacy of KALOMIN Tab in acute bronchitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis [Phase 2]
Phase 2 trial sponsored by PharmaKing evaluating efficacy for acute exacerbations of chronic bronchitis and for chronic bronchitis has compl…
-
CLINICAL_TRIALS research · 2014-05-16Clinical Trial Update: A Comparison Study of Two Respiratory Physical Therapy Methods and Standard Medical Treatment for Treating COPD Patients During Acute Exacerbation [NA]
A clinical trial update evaluating two respiratory physical therapy methods plus standard medical treatment for COPD patients during acute e…
-
CLINICAL_TRIALS withdrawal · 2014-03-27Clinical Trial Update: Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive Bronchitis [Phase 2]
Phase 2 trial evaluating 4-week treatment with BIBW 2948 BS in chronic obstructive pulmonary disease with chronic bronchitis; the study has …
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: Tolerance and Effect of a Prophylactical Treatment With Ivy Leaves Dry Extract in Recurrent Wheezy Bronchitis [Phase 2]
Phase 2 clinical trial update evaluating tolerance and preliminary effects of Ivy leaf extract given prophylactically for recurrent wheezy b…
-
FDA approval · 2013-11-22FDA Approved: CEFIXIME — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for cefixime. This action updates the cefixime NDA, potentially expanding i…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis [Phase 2]
Phase 2 study evaluating safety, tolerability, and efficacy of YHD001 in patients with acute and chronic bronchitis. The trial has completed…
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema) [Phase 3]
A Phase 3 trial evaluating GW815SF for chronic obstructive pulmonary disease (including chronic bronchitis and emphysema) has completed.
-
CLINICAL_TRIALS research · 2013-04-05Clinical Trial Update: A Registry Study on Tanreqing（a Chinese Medicine Injection）Used in Hospitals in China
A registry study investigating the use of Tanreqing injection in hospitals in China for pneumonia and bronchitis.
-
FDA approval · 2013-03-29FDA Approved: CEFIXIME — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for cefixime from Lupin Pharmaceuticals, Inc. to modify/extend its labeling and/or approval.
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Mucus Dehydration and Evolution of Chronic Obstructive Pulmonary Disease (COPD) Lung Disease
A completed clinical trial update examining mucus dehydration and the evolution of COPD lung disease. The study concerns Chronic Obstructive…
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Patients With Acute Exacerbation of Chronic Bronchitis
Outcome study evaluating Klaricid XL (clarithromycin modified release) in patients with acute exacerbation of chronic bronchitis has complet…